Epicutaneous Immunotherapy in Peanut Allergy in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

February 28, 2015

Study Completion Date

April 30, 2015

Conditions
Peanut Allergy
Interventions
BIOLOGICAL

Epicutaneous Immunotherapy

100 mcg peanut proteins (active arm) applied on the skin every 24 hrs for 6 months blinded, followed by 12 months open treatment for all patients in the active arm

BIOLOGICAL

placebo of peanut

placebo applied on the skin every 24 hrs for 6 months blinded, followed by 12 months open treatment for all patients in the active arm

Trial Locations (1)

75015

Hopital Necker, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

DBV Technologies

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01197053 - Epicutaneous Immunotherapy in Peanut Allergy in Children | Biotech Hunter | Biotech Hunter